Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 45 Uterine Cervical Neoplasms 10 Melanoma 10 Endometrial Neoplasms 9 Mouth Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Carcinoma, Intraductal, Noninfiltrating 4 Vulvar Neoplasms 3 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Uterine Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Micrometastasis 2 Neoplasm Metastasis 2 Lymphatic Metastasis 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Eccrine Porocarcinoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Breast Carcinoma In Situ 2 Anus Neoplasms 2 Waldenstrom Macroglobulinemia 1 Sentinel Lymph Node Biopsy (SLNB) 1 Sentinel Lymph Node 1 Sarcoidosis, Pulmonary 1 Sarcoidosis 1 Rhabdomyosarcoma 1 Recurrence 1

Interventions

pembrolizumab 29 avelumab 21 Nivolumab 20 Ipilimumab 10 Radiotherapy 9 Cyclophosphamide 9 atezolizumab 8 cemiplimab 7 fludarabine 6 Specimen Handling 6 durvalumab 5 aldesleukin 5 Radiation 5 Magnetic Resonance Spectroscopy 5 Interleukin-2 5 Biopsy 5 talimogene laherparepvec 4 ALT-803 4 poly ICLC 3 Radiosurgery 3 Etoposide 3 Cisplatin 3 Carboplatin 3 CTLA-4 Antigen 3 Bevacizumab 3 prednylidene 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 domatinostat 2 deltacortene 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Sentinel Lymph Node Biopsy × Clear all

NCT05797415 2024-10-01

BLS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Carcinoma, Merkel Cell, Eccrine Porocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡